Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.
Cindi G MarinhoHyder A MeloRoberto SalvatoriMarco A P NunesCarla R P OliveiraViviane C CamposCynthia S Barros-OliveiraAlécia A Oliveira-SantosNelmo V MenezesHertz T Santos-JúniorElenilde G SantosManuela A MeloJoselina L M OliveiraEnaldo V MeloManuel H Aguiar-OliveiraPublished in: Endocrine (2020)
Lifetime, untreated IGHD does not cause impaired cerebral vasoreactivity.